Institute of Biotechnology CAS

Three international research teams succeded in elucidation of a unique molecular mechanism, which enables bacteria, including pathogens, to maintain the flow of genetic information from DNA to RNA. The discovery leads to new possibilities of development of the much needed antimicrobials against serious pathogens, including the causative agent of tuberculosis. Their discoveries have been published in the journal Nature Communications.

MAXIMISING THE ACCESSIBILITY OF RESEARCH RESULTS IN THE FIGHT AGAINST COVID-19

We report on a unique glass microfluidic Y-system with planar immunocapture channel working in so-called stop-flow dynamic regime.

In October 2020 a new research group started at the Institute of Biotechnology (IBT) of the Czech Academy of Sciences located at the BIOCEV center. Head of the group, Dr. Katerina Rohlenova, returned to the Czech Republic after a postdoctoral stay in the laboratory of Prof. Peter Carmeliet at the Center for Cancer Biology (VIB-KU Leuven) in Belgium, where she studied metabolism of cells that form blood vessels in tumors. At IBT Katerina teamed-up with Dr. ...

An international team led by researchers from the Institute of Biotechnology of the Czech Academy of Sciences describes a mechanism underlying transport of organelles within cells. The work shows how long-range transport can efficiently work in crowded cellular environments.

Our study on interactions between human PSMA and an RNA-based aptamer on Nucl Acid Res cover page

We have published a unique automated methods of nucleic acid classification and annotation.

The Centre of Molecular Structure introduces its newsletter with updates on its 4 core facilities: new instruments, upgrades of current instruments, or the new service „Crystallization and Diffraction screening from your couch“. You will find details in attachment.

Cerebral stroke is one of the leading causes of death and long-term disability worldwide. It affects primarily the elderly population and is typically recognized as a disease associated with aging. However, it remains unknown how such an age-dependent vulnerability develops, and what are the underlying mechanisms. ...

If the cancer cells have little or extremely much iron, they will not be able to cope and die, "describes one of the possible future strategies to fight cancer Mgr. JAROSLAV TRUKSA, Ph.D. D., from the Institute of Biotechnology of the CAS.